Business
CBAK Energy Technology is a Nevada holding company whose China subsidiaries develop and manufacture high-power cylindrical lithium batteries, battery packs, cathode materials, and precursors.
CBAK Energy grew FY2025 revenue, but profits swung to a loss as margins compressed and capex rose.
The read at a glance✓ Audited against SEC data
- Business mix — China lithium batteriesNote
- Revenue — $195.2M, +10.5%OK
- Net income — ($9.4M), from $11.8MWatch
- FCF — $3.9M, -82.7%Watch
- Margins — Gross margin 9.44%, -1421 bpsWatch
- Insiders — 0 purchases and 0 salesNote
- Accounting — Altman weak; Beneish clean; EQ greyWatch
Where the revenue comes from
Fiscal 2025, as CBAK Energy Technology, Inc. reports it. History and quarterly detail are in the app.
- High Power Lithium Batteries$106.0M
- Manufacturing Lithium Batteries$89.2M
- Cathode$82.5M
- Residential Energy Supply And Uninterruptable Supplies$68.8M
- Light Electric Vehicles$36.4M
Leadership changes
From CBAK Energy Technology, Inc.'s own filings, the day they're filed.
- Yunfei Li · Chief Executive Officer · departureeff. 2024-10-24
- Jiewei Li · Chief Financial Officer · appointmenteff. 2023-08-22
- Zhiguang Hu · Chief Executive Officer · appointment
Latest filings
- 8-K · Company announcement2026-06-23
- 10-Q · Quarterly report2026-05-18
- 8-K · Company announcement2026-05-18
- 8-K · Company announcement2026-05-01
- 10-K · Annual report2026-03-31
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CBAK Energy Technology, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.